Difficulties in Applying the Scatchard Model of Ligand Binding to Proteins--proposal of New Mathematical Tools--application to Salicylates
Overview
Pharmacy
Affiliations
Ill-considered use of the Scatchard model often leads to unjustified deductions. Since the main difficulty of this model is its number of parameters, new models are proposed that have only two parameters. After checking the models on simulated data, they were applied to real data on the binding of salicylates to albumin.
Protein binding and stereoselectivity of nonsteroidal anti-inflammatory drugs.
Lapicque F, Muller N, Payan E, Dubois N, Netter P Clin Pharmacokinet. 1993; 25(2):115-23.
PMID: 8403735 DOI: 10.2165/00003088-199325020-00004.
Decrease of in vitro serum protein binding of salicylate in rheumatoid arthritis.
Netter P, Monot C, Stalars M, Mur J, Royer R, Faure G Eur J Drug Metab Pharmacokinet. 1984; 9(2):109-16.
PMID: 6745302 DOI: 10.1007/BF03189613.
Ultrafiltration vs equilibrium dialysis for determination of free fraction.
BOWERS W, Fulton S, Thompson J Clin Pharmacokinet. 1984; 9 Suppl 1:49-60.
PMID: 6705427 DOI: 10.2165/00003088-198400091-00007.